PT  - JOURNAL ARTICLE
AU  - Liu, Andrew H.
AU  - Hootman, Julia
AU  - Li, Dongmei
AU  - Xie, Zidian
TI  - Public perceptions of synthetic cooling agents in electronic cigarettes on Twitter
AID  - 10.1101/2023.09.21.23295881
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.09.21.23295881
4099  - http://medrxiv.org/content/early/2023/09/25/2023.09.21.23295881.short
4100  - http://medrxiv.org/content/early/2023/09/25/2023.09.21.23295881.full
AB  - Amid a potential menthol ban, electronic cigarette (e-cigarette) companies are incorporating synthetic cooling agents like WS-3 and WS-23 to replicate menthol/mint sensations. This study examines public views on synthetic cooling agents in e-cigarettes via Twitter data. From May 2021 to March 2023, we used Twitter Streaming API, to collect tweets related to synthetic cooling agents with keywords such as ‘WS-23,’ ’ice,’ and ’frozen.’ Two deep learning roBERTa models, classified attitudes expressed in tweets about synthetic cooling agents and identified e-cigarette users. The BERTopic deep-learning model identified major topics of positive and negative tweets. Two proportion Z-tests were used to compare the proportions of positive and negative attitudes between e-cigarette users (vapers) and non-e-cigarette-users (non-vapers). Of 6,940,065 e-cigarettes related tweets, 5,788 non-commercial tweets related to synthetic cooling agents. The longitudinal trend analysis showed a clear upwards trend in discussions. Vapers posted most of the tweets (73.05%, 4,228/5,788). Nearly half (47.87%, 2,771/5,788) held a positive attitude toward synthetic cooling agents, which is significantly higher than those with a negative attitude (19.92%,1,153/5,788) with a P-value < 0.0001. The likelihood of Vapers expressing positive attitudes (60.17%, 2,544/4,228) was significantly higher (P < 0.0001) than that from non-vapers (14.55%, 227/1,560). Conversely, negative attitudes from non-vapers (30%, 468/1,560) was significantly (P < 0.0001) higher than vapers (16.2%, 685/4,228). Prevalent topics from positive tweets included “enjoyment of specific vape flavors,” “preference for lush ice vapes,” and “liking of minty/icy feelings.” Major topics from negative tweets included “disliking certain vape flavors” and “dislike of others vaping around them.” On Twitter, vapers are more likely to have a positive attitude toward synthetic cooling agents than non-vapers. Our study provides important insights into how the public perceives synthetic cooling agents in e-cigarettes, insights that are crucial for shaping future FDA regulations aimed at safeguarding public health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by REU Site: Computational Methods for Understanding Music, Media, and Minds grant funded by National Science Foundation (Award number: 1950460) (AL and JH) and by the WNY Center for Research on Flavored Tobacco Products (CRoFT) under cooperative agreement U54CA228110 funded by National Cancer Institute and US Food and Drug Administration (FDA) (DL and ZX). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the FDA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and approved by the Research Subjects Review Board of the Office for Human Subject Protection at the University of Rochester (STUDY00006570).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableData are available upon reasonable request through corresponding author.